miR-708 has been identified as a key regulator of tumor progression and chemoresistance in ES, acting through the modulation of EYA3 (Eyes Absent Homolog 3), a tyrosine phosphatase involved in DNA damage repair [113,143]. Here, EYA3 is linked to neoplasm.